Dr. Catherine Willett, HSUS Director of Regulatory Toxicology, Risk Assessment, and Alternatives, and coordinator of the Human Toxicology Project Consortium, testified Tuesday before the US House of Representatives Energy and Commerce Subcommittee on Environment and the Economy, on the testing and reporting requirements included in the Toxic Substances Control Act (TSCA). The subcommittee has been conducting a series of information-gathering hearings as it considers ways to revise and update the law (enacted in 1976 and amended in 2002). Dr. Willett testified that effective modification of TSCA must support and encourage the EPA to continue on the path of developing and using computational, cell, and tissue-based alternative methods to prioritize and test the chemicals covered by TSCA. “By articulating this in any legislative proposal, Congress will also send a strong message that more effective chemical regulation is dependent on more effective and humane chemicals testing.” Dr. Willett urged that language in any update or revision to TSCA require the use of validated alternative methods in place of animal tests as those methods become available. “Protecting human health and the environment is the critical goal of effective chemicals regulation. In order to achieve this goal, it’s necessary for any new legislation to allow and support the continuing evolution of the science of chemical assessment.”
Written testimony can be found here.